Scil Proteins

Scil Proteins

Advanced protein engineering solutions for biopharma and life sciences, enhancing drug development and therapeutic innovations.

  • Edit
DateInvestorsAmountRound

€24.0m

Late VC
Total Funding000k
Notes (0)
More about Scil Proteins
Made with AI
Edit

Scil Proteins is a specialized company focused on providing advanced protein engineering solutions to the biopharma and life sciences sectors. The company operates in the biotechnology market, serving clients that include pharmaceutical companies, research institutions, and healthcare providers. Scil Proteins' business model revolves around offering customized protein engineering services, which include protein design, production, and optimization. These services are crucial for drug development, therapeutic innovations, and various biotechnological applications. The company generates revenue through service contracts, research collaborations, and licensing agreements. By leveraging cutting-edge technologies such as artificial intelligence and cloud computing, Scil Proteins ensures efficient data management and innovative solutions for its clients. The company is also involved in educational initiatives, such as the Rainer Rudolph Foundation, which aims to nurture young talents in protein biotechnology.

Keywords: protein engineering, biopharma, life sciences, drug development, therapeutic innovations, biotechnology, AI, cloud computing, research collaborations, educational initiatives.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo